Selected Publications

Myers RM, Mumanachit S, Maude SL, Dinofia AM, Freedman JL, Bunin N, Wray L, Barz AL, Olson TS, Grupp S, Seif AE, Elgarten CW: 3767 Outcomes and Toxicities after Allogeneic Hematopoietic Cell Transplant for Remission Consolidation or Relapse Therapy after CD19 Chimeric Antigen Receptor T Cell Therapy in Children and Young Adults with Acute Lymphoblastic Leukemia. American Society of Hematology December 2023.

Freedman J, Phillips C, Wray L, Smith L, McGuire R, Bailer J: Enteral Nutrition Post Pediatric Hematopoietic Stem Cell Transplant. Multinational Association of Supportive Care in Cancer/JASCC/ISOO June 2023.

Fraint E, Abdel-Azim H, Bhatt N, Broglie L, Chattha A, Kohorst M, Ktena Y, Lee M, Long S, Qayed M, Sharma A, Stefanski H, Vatsayan A, Wray L, Hamadani M, Carpenter P: Evaluation of children with malignancies for blood and marrow transplantation: A report from the ASTCT Committee on Practice Guidelines. Transplantation and Cellular Therapy Page: doi: 10.1016, February 2023 Notes: epub ahead of print.

Aredas B, Wray L, Ellison A et al.: Doing The Work To Create A Diverse, Equitable and Anti-racist Environment in Academic Medicine. Pediatric Academic Societies Meeting, Denver, CO April 2022 Notes: Podium presentation.

Leahy AB, Devine KJ, Li Y, Liu H, Myers R, DiNofia A, Wray L, Rheingold SR, Callahan C, Baniewicz D, Patino M, Newman H, Hunger SP, Grupp SA, Barrett DM, Maude SL: Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy. Blood April 2022.

Ruiz J, Wray L, Kline C et al. : Implementing a Diversity, Equity and Antiracism Curriculum in a single institution Cancer Center. Pediatric Academic Societies Meeting, Denver, CO April 2022 Notes: Podium presentation.

Leahy AB, Newman H, Li Y, Liu H, Myers R, DiNofia A, Dolan JG, Callahan C, Baniewicz D, Devine K, Wray L, Aplenc R, June CH, Grupp SA, Rheingold SR, Maude SL: CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials. The Lancet Haematology 8(10): e711-e722, October 2021.

Myers R, Li Y, Leahy A, Barrett D, Teachey D, Callahan C, Fasano C, Rheingold S, DiNofia A, Wray L, Aplenc A, Baniewicz D, Liu H, Shaw P, Pequignot E, Getz K, Brogdon J, Fesnak A, Siegel D, Davis M, Bartoszek C, Lacey S, Hexner E, Chew A, Wertheim G, Levine B, June C, Grupp S, Maude S: Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T cells in CAR-Naïve and CAR-Exposed Children and Young adults with Relasped/Refractory Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 39(27): 3044-3055, September 2021.

Stephan Kadauke, MD, PhD; Regina M. Myers, MD; Yimei Li, PhD; Richard Aplenc, MD, PhD; Diane Baniewicz, CRNP; David M. Barrett, MD, PhD; Allison Barz Leahy, MD; Colleen Callahan, CRNP; Joseph G. Dolan, MD; Julie C. Fitzgerald, MD, PhD; Whitney Gladney, PhD; Simon F. Lacey, PhD; Hongyan Liu, PhD; Shannon L. Maude, MD, PhD; Regina McGuire, BA; Laura S. Motley, RN; David T. Teachey, MD; Gerald B. Wertheim, MD, PhD; Lisa Wray, MD; Amanda M. DiNofia, MD; and Stephan A. Grupp, MD, PhD: Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial. Journal of Clinical Oncology 39(8): 920-930, March 2021.

Fraint E, Holuba M, Wray L: Pediatric Hematopoietic Stem Cell Transplant. Pediatrics in Review 41(11): 609-611, November 2020.